Inoviq
Inoviq is an Australian biotechnology company focused on developing and commercializing innovative cancer diagnostic products. The company's focus is on improving cancer detection and monitoring through its proprietary technologies. Inoviq aims to address unmet needs in cancer diagnostics, offering potential benefits for patients and healthcare providers.
Short position
Inoviq (ASX:IIQ) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 27 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.58% in October 2025. IIQ is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Inoviq (IIQ) company profile
Profile, insiders and operations
Company
AI-generated research profile of Inoviq
IIQ intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links